造血干细胞-话题@MedSci

#造血干细胞#

227篇内容 | 6025人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1271506, encodeId=8e7612e1506e3, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Blood：GPRASP蛋白是造血干细胞移植的重要负性调控因子, objectType=article, longId=187713, objectId=534b18e71307, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=534b18e71307, replyNumber=0, likeNumber=97, createdTime=2020-02-10, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=534b18e71307, moduleTitle=Blood：GPRASP蛋白是造血干细胞移植的重要负性调控因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=534b18e71307)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271505, encodeId=d47a12e150527, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Blood：异基因造血干细胞移植后非复发性死亡的预后标志物, objectType=article, longId=187352, objectId=f9be18e3525e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9be18e3525e, replyNumber=0, likeNumber=71, createdTime=2020-02-05, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9be18e3525e, moduleTitle=Blood：异基因造血干细胞移植后非复发性死亡的预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9be18e3525e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271504, encodeId=e64012e1504a5, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=儿童造血干细胞移植相关的血栓性微血管病：Nomacopan关键性III期临床试验, objectType=article, longId=185186, objectId=397c185186ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=397c185186ea, replyNumber=0, likeNumber=29, createdTime=2019-12-26, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=397c185186ea, moduleTitle=儿童造血干细胞移植相关的血栓性微血管病：Nomacopan关键性III期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=397c185186ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271503, encodeId=6f6112e150368, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=2019 JSHCT临床实践建议：异基因造血干细胞移植后人类疱疹病毒6B脑炎的诊断和管理, objectType=article, longId=183766, objectId=cd40183e661a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd40183e661a, replyNumber=0, likeNumber=28, createdTime=2019-11-30, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd40183e661a, moduleTitle=2019 JSHCT临床实践建议：异基因造血干细胞移植后人类疱疹病毒6B脑炎的诊断和管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd40183e661a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271502, encodeId=e58812e150228, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=2019 儿童肿瘤和造血干细胞移植患者抗菌预防管理指南, objectType=article, longId=183309, objectId=b904183309f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b904183309f7, replyNumber=0, likeNumber=43, createdTime=2019-11-21, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b904183309f7, moduleTitle=2019 儿童肿瘤和造血干细胞移植患者抗菌预防管理指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b904183309f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271501, encodeId=03af12e1501f9, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=神奇伟哥的妙用：加速造血干细胞新生！, objectType=article, longId=181893, objectId=51b61818934f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51b61818934f, replyNumber=0, likeNumber=33, createdTime=2019-10-26, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51b61818934f, moduleTitle=神奇伟哥的妙用：加速造血干细胞新生！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51b61818934f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271500, encodeId=cf6812e15006a, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Stem Cell Rep：万艾可有望用于造血干细胞移植, objectType=article, longId=181273, objectId=1ef21812e34e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ef21812e34e, replyNumber=0, likeNumber=60, createdTime=2019-10-17, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ef21812e34e, moduleTitle=Stem Cell Rep：万艾可有望用于造血干细胞移植, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ef21812e34e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271499, encodeId=c7e212e149904, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Lancet Haematol：苏消安联合氟达拉滨用于异基因造血干细胞移植术前处理, objectType=article, longId=180921, objectId=5b5618092125, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b5618092125, replyNumber=0, likeNumber=73, createdTime=2019-10-12, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b5618092125, moduleTitle=Lancet Haematol：苏消安联合氟达拉滨用于异基因造血干细胞移植术前处理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b5618092125)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271498, encodeId=f36212e1498ca, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=上海累计实现467例造血干细胞捐献公益话剧《髓愿》首演, objectType=article, longId=180547, objectId=68dd18054e3c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68dd18054e3c, replyNumber=0, likeNumber=52, createdTime=2019-10-07, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68dd18054e3c, moduleTitle=上海累计实现467例造血干细胞捐献公益话剧《髓愿》首演, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68dd18054e3c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271497, encodeId=a0be12e14979a, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Akari的补体抑制剂nomacopan治疗造血干细胞移植相关血栓性微血管病变，获得FDA的孤儿药指定, objectType=article, longId=178530, objectId=2cdd1e853070, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cdd1e853070, replyNumber=0, likeNumber=64, createdTime=2019-09-03, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cdd1e853070, moduleTitle=Akari的补体抑制剂nomacopan治疗造血干细胞移植相关血栓性微血管病变，获得FDA的孤儿药指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cdd1e853070)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271496, encodeId=392412e1496fa, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Blood：KDM4/JMJD2组蛋白去甲基化对造血干细胞的维持至关重要, objectType=article, longId=178232, objectId=05f81e823285, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05f81e823285, replyNumber=0, likeNumber=63, createdTime=2019-08-28, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05f81e823285, moduleTitle=Blood：KDM4/JMJD2组蛋白去甲基化对造血干细胞的维持至关重要, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05f81e823285)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271495, encodeId=4c5e12e149570, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Blood：多种受体酪氨酸激酶信号介导急性血小板减少时的造血干细胞反应, objectType=article, longId=178231, objectId=208f1e823181, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=208f1e823181, replyNumber=0, likeNumber=71, createdTime=2019-08-28, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=208f1e823181, moduleTitle=Blood：多种受体酪氨酸激酶信号介导急性血小板减少时的造血干细胞反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=208f1e823181)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271494, encodeId=c36412e14945a, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Akari的补体抑制剂Nomacopan治疗小儿造血干细胞移植相关血栓性微血管病，获得FDA快速通道指定, objectType=article, longId=177725, objectId=7f3b1e772586, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f3b1e772586, replyNumber=0, likeNumber=59, createdTime=2019-08-17, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f3b1e772586, moduleTitle=Akari的补体抑制剂Nomacopan治疗小儿造血干细胞移植相关血栓性微血管病，获得FDA快速通道指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f3b1e772586)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271493, encodeId=6a8312e14930f, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=SCI TRANS MED：CRISPR-Cas9编辑造血干细胞，助力治疗相关移植, objectType=article, longId=176793, objectId=62aa1e679336, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62aa1e679336, replyNumber=0, likeNumber=47, createdTime=2019-08-05, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62aa1e679336, moduleTitle=SCI TRANS MED：CRISPR-Cas9编辑造血干细胞，助力治疗相关移植, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62aa1e679336)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271492, encodeId=218f12e14924c, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=JAMA：疫苗可有效降低自体造血干细胞移植后带状疱疹发生率, objectType=article, longId=175264, objectId=29bb1e5264d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29bb1e5264d5, replyNumber=0, likeNumber=101, createdTime=2019-07-13, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29bb1e5264d5, moduleTitle=JAMA：疫苗可有效降低自体造血干细胞移植后带状疱疹发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29bb1e5264d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271491, encodeId=80d812e149143, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=《自然》：重大突破！普通胶水破解造血干细胞体外扩增的谜题, objectType=article, longId=168030, objectId=fdca16803091, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdca16803091, replyNumber=0, likeNumber=63, createdTime=2019-06-12, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdca16803091, moduleTitle=《自然》：重大突破！普通胶水破解造血干细胞体外扩增的谜题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdca16803091)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271490, encodeId=5ef212e14909f, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=英国NICE推荐将MSD的Prevymis，用于造血干细胞移植后巨细胞病毒的控制, objectType=article, longId=167613, objectId=b87a16e61344, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b87a16e61344, replyNumber=0, likeNumber=83, createdTime=2019-06-05, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b87a16e61344, moduleTitle=英国NICE推荐将MSD的Prevymis，用于造血干细胞移植后巨细胞病毒的控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b87a16e61344)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271489, encodeId=af1212e148935, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Be The Match BioTherapies和Kiadis Pharma宣布战略合作以加速造血干细胞移植疗法, objectType=article, longId=166721, objectId=b315166e2142, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b315166e2142, replyNumber=0, likeNumber=69, createdTime=2019-05-25, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b315166e2142, moduleTitle=Be The Match BioTherapies和Kiadis Pharma宣布战略合作以加速造血干细胞移植疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b315166e2142)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271488, encodeId=8ac012e1488ff, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=新一代造血干细胞动员剂释倍灵®开出中国首张处方，显著提升非霍奇金淋巴瘤患者移植成功率, objectType=article, longId=164478, objectId=d8c61644e8a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8c61644e8a3, replyNumber=0, likeNumber=65, createdTime=2019-04-19, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8c61644e8a3, moduleTitle=新一代造血干细胞动员剂释倍灵®开出中国首张处方，显著提升非霍奇金淋巴瘤患者移植成功率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8c61644e8a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271487, encodeId=efb112e1487d8, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Lancet haemat：慢病毒造血干细胞基因编辑疗法用于Wiskott-Aldrich综合征患儿的临床疗效和安全性评估, objectType=article, longId=164438, objectId=87fe1644385f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87fe1644385f, replyNumber=0, likeNumber=76, createdTime=2019-04-18, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87fe1644385f, moduleTitle=Lancet haemat：慢病毒造血干细胞基因编辑疗法用于Wiskott-Aldrich综合征患儿的临床疗效和安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87fe1644385f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

造血干细胞

2020-05-29

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Blood：GPRASP蛋白是造血干细胞移植的重要负性调控因子

2020-02-10

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Blood：异基因造血干细胞移植后非复发性死亡的预后标志物

2020-02-05

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

儿童造血干细胞移植相关的血栓性微血管病：Nomacopan关键性III期临床试验

2019-12-26

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

2019 JSHCT临床实践建议：异基因造血干细胞移植后人类疱疹病毒6B脑炎的诊断和管理

2019-11-30

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

2019 儿童肿瘤和造血干细胞移植患者抗菌预防管理指南

2019-11-21

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

神奇伟哥的妙用：加速造血干细胞新生！

2019-10-26

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Stem Cell Rep：万艾可有望用于造血干细胞移植

2019-10-17

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Lancet Haematol：苏消安联合氟达拉滨用于异基因造血干细胞移植术前处理

2019-10-12

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

上海累计实现467例造血干细胞捐献公益话剧《髓愿》首演

2019-10-07

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Akari的补体抑制剂nomacopan治疗造血干细胞移植相关血栓性微血管病变，获得FDA的孤儿药指定

2019-09-03

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Blood：KDM4/JMJD2组蛋白去甲基化对造血干细胞的维持至关重要

2019-08-28

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Blood：多种受体酪氨酸激酶信号介导急性血小板减少时的造血干细胞反应

2019-08-28

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Akari的补体抑制剂Nomacopan治疗小儿造血干细胞移植相关血栓性微血管病，获得FDA快速通道指定

2019-08-17

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

SCI TRANS MED：CRISPR-Cas9编辑造血干细胞，助力治疗相关移植

2019-08-05

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

JAMA：疫苗可有效降低自体造血干细胞移植后带状疱疹发生率

2019-07-13

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

《自然》：重大突破！普通胶水破解造血干细胞体外扩增的谜题

2019-06-12

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

英国NICE推荐将MSD的Prevymis，用于造血干细胞移植后巨细胞病毒的控制

2019-06-05

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Be The Match BioTherapies和Kiadis Pharma宣布战略合作以加速造血干细胞移植疗法

2019-05-25

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

新一代造血干细胞动员剂释倍灵®开出中国首张处方，显著提升非霍奇金淋巴瘤患者移植成功率

2019-04-19

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Lancet haemat：慢病毒造血干细胞基因编辑疗法用于Wiskott-Aldrich综合征患儿的临床疗效和安全性评估

2019-04-18

科室
- - 订阅+
  - 更多科室
工具
服务